Education
About Us
Working with TipRanks
Follow Us
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 881.71K | $ 3.94M |
| Gross Profit | $ -600.00K | $ -31.17M | $ -1.49M | $ -757.53K | $ 3.84M |
| Operating Income | $ -48.72M | $ -45.08M | $ -34.84M | $ -55.99M | $ -122.81M |
| EBITDA | $ -37.74M | $ -44.44M | $ -38.73M | $ -54.97M | $ -121.69M |
| Net Income | $ -40.21M | $ -44.60M | $ -55.83M | $ -45.55M | $ -111.30M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 149.06M | $ 20.91M | $ 59.20M | $ 97.65M | $ 85.43M |
| Total Assets | $ 155.88M | $ 28.27M | $ 66.31M | $ 107.73M | $ 102.29M |
| Total Debt | $ 3.24M | $ 20.88M | $ 25.09M | $ 26.59M | $ 26.84M |
| Net Debt | $ -13.96M | $ 7.16M | $ 8.09M | $ 1.58M | $ -58.60M |
| Total Liabilities | $ 13.45M | $ 35.18M | $ 33.32M | $ 38.62M | $ 57.02M |
| Stockholders' Equity | $ 142.43M | $ -6.90M | $ 32.99M | $ 69.11M | $ 45.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -41.79M | $ -36.10M | $ -37.56M | $ -48.24M | $ -100.17M |
| Operating Cash Flow | $ -41.79M | $ -36.10M | $ -37.54M | $ -48.18M | $ -99.69M |
| Investing Cash Flow | $ -121.31M | $ 35.64M | $ 30.07M | $ -73.42M | $ -484.49K |
| Financing Cash Flow | $ 166.58M | $ -2.82M | $ -533.62K | $ 60.82M | $ 154.87M |